- Home
- PODC vs NXPL Comparison
PODC vs NXPL Comparison
Compare PODC & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODC
- NXPL
- Stock Information
- Founded
- PODC 2013
- NXPL 1997
- Country
- PODC United States
- NXPL United States
- Employees
- PODC N/A
- NXPL N/A
- Industry
- PODC
- NXPL Telecommunications Equipment
- Sector
- PODC
- NXPL Telecommunications
- Exchange
- PODC Nasdaq
- NXPL Nasdaq
- Market Cap
- PODC 29.7M
- NXPL 32.5M
- IPO Year
- PODC N/A
- NXPL N/A
- Fundamental
- Price
- PODC $2.01
- NXPL $0.98
- Analyst Decision
- PODC Strong Buy
- NXPL
- Analyst Count
- PODC 2
- NXPL 0
- Target Price
- PODC $4.75
- NXPL N/A
- AVG Volume (30 Days)
- PODC 32.9K
- NXPL 83.2K
- Earning Date
- PODC 02-12-2025
- NXPL 04-10-2025
- Dividend Yield
- PODC N/A
- NXPL N/A
- EPS Growth
- PODC N/A
- NXPL N/A
- EPS
- PODC N/A
- NXPL N/A
- Revenue
- PODC $49,729,000.00
- NXPL $66,482,000.00
- Revenue This Year
- PODC $20.42
- NXPL N/A
- Revenue Next Year
- PODC $19.38
- NXPL N/A
- P/E Ratio
- PODC N/A
- NXPL N/A
- Revenue Growth
- PODC 22.98
- NXPL 179.89
- 52 Week Low
- PODC $1.10
- NXPL $0.71
- 52 Week High
- PODC $2.85
- NXPL $2.68
- Technical
- Relative Strength Index (RSI)
- PODC 42.53
- NXPL 43.52
- Support Level
- PODC $1.87
- NXPL $0.96
- Resistance Level
- PODC $2.30
- NXPL $1.12
- Average True Range (ATR)
- PODC 0.23
- NXPL 0.09
- MACD
- PODC -0.01
- NXPL -0.00
- Stochastic Oscillator
- PODC 30.00
- NXPL 39.13
About PODC PodcastOne Inc.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.
About NXPL NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.